1) Decoy receptor 3
诱捕受体3
1.
Expression and significance of decoy receptor 3 in human hepatocellular carcinoma cell Lines;
目的探讨肝癌细胞系诱捕受体3(DcR3)的表达变化及意义。
2) Decoy receptor 3
诱骗受体3
1.
Decoy receptor 3:A novel target for gene therapy of cancer;
诱骗受体3—肿瘤基因治疗的新靶点
2.
Decoy receptor 3,tumor necrosis factor receptor 6B or called TR6,is a newly member of tumor necrosis receptor superfamily.
诱骗受体3(D cR3)又称肿瘤坏死因子受体-6B(TNFR-6B或TR6),也有人称之为TR6,是新近发现的TNFR超家族成员,它具有调节细胞凋亡和免疫细胞活性及分化的生物学特性,D cR3在肿瘤免疫、自身免疫、移植免疫及抗感染免疫中发挥着重要作用。
3.
Objective To investigate the expressions of Fas, Fas ligand (FasL), and decoy receptor 3 (DcR3) in different endocrine types of human pituitary adenomas.
第一章Fas、Fas配体(FasL)和诱骗受体3(DcR3)在人垂体腺瘤组织中的表达 目的检测Fas、Fas配体(FasL)和诱骗受体3(DcR3)的蛋白和mRNA在人各内分泌类型垂体腺瘤组织中的表达水平。
3) Decoy receptor 3(DcR3)
诱导受体3
4) DcR3
死亡诱骗受体3
5) Decoy receptor
诱骗受体
1.
[Objective] : To study the role of TRAIL in the treatment of cervical carcinoma, we analyzed the sensitivity of cervical carcinoma cell to TRAIL killing in the context of the expression of different TRAIL receptors, and we studied the relative expression level of death receptors (DR4、 DR5) and decoy receptors (DcR1、 DcR2) of TRAIL in cervical carcinoma cell line Hela.
[目的]:通过检测宫颈癌细胞Hela表面TRAIL死亡受体(DR4、DR5)及诱骗受体(DcR1、DcR2)的表达差异,观察Hela细胞系对TRAIL蛋白诱导凋亡敏感程度,分析细胞系表面DR4、DR5与DcR1、DcR2表达的相对程度与TRAIL诱导凋亡敏感性间的差异。
补充资料：诱捕
1.引诱捕捉。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条